Pemetrexed monotherapy as salvage treatment in metastatic colorectal cancer patients who failed standard chemotherapy: A phase II single-arm prospective trial.

被引：0
|
作者：
Lim, Sung Won [1 ]
Cho, Jangho [1 ]
Lee, Jeeyun [1 ]
Park, Se Hoon [1 ]
Park, Joon Oh [1 ]
Park, Young Suk [1 ]
Lim, Ho Yeong [1 ]
Kang, Won Ki [1 ]
Kim, Seung Tae [1 ]
机构：
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.840
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
840
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: study protocol for a multicenter, prospective, single-arm, phase II trial
    Leng, Weibing
    Wen, Zhenpeng
    Wang, Han
    Cao, Peng
    Liu, Jiyan
    Luo, Deyun
    Qiu, Meng
    BMC CANCER, 2025, 25 (01)
  • [22] Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
    Kuang, Chaoyuan
    Park, Yongseok
    Augustin, Ryan C.
    Lin, Yan
    Hartman, Douglas J.
    Seigh, Lindsey
    Pai, Reetesh K.
    Sun, Weijing
    Bahary, Nathan
    Ohr, James
    Rhee, John C.
    Marks, Stanley M.
    Beasley, H. Scott
    Shuai, Yongli
    Herman, James G.
    Zarour, Hassane M.
    Chu, Edward
    Lee, James J.
    Krishnamurthy, Anuradha
    CLINICAL EPIGENETICS, 2022, 14 (01)
  • [23] Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
    Chaoyuan Kuang
    Yongseok Park
    Ryan C. Augustin
    Yan Lin
    Douglas J. Hartman
    Lindsey Seigh
    Reetesh K. Pai
    Weijing Sun
    Nathan Bahary
    James Ohr
    John C. Rhee
    Stanley M. Marks
    H. Scott Beasley
    Yongli Shuai
    James G. Herman
    Hassane M. Zarour
    Edward Chu
    James J. Lee
    Anuradha Krishnamurthy
    Clinical Epigenetics, 2022, 14
  • [24] A prospective phase II study of raltitrexed combined with S-1 as salvage treatment for patients with metastatic colorectal cancer after failure of standard chemotherapy.
    Huang, Mingzhu
    Chen, Zhiyu
    Wang, Yusheng
    Zhu, Xiaodong
    Zhang, Wen
    Zhang, Xiaowei
    Zhao, Xiaoying
    Qiu, Lixin
    Wang, Chenchen
    Guo, Weijian
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] Pemetrexed monotherapy in patients with advanced non-small cell lung cancer who have had prior chemotherapy: A prospective phase II trial
    Lee, H.
    Ahn, M.
    Ahn, J.
    Kwon, J.
    Lee, S.
    Bae, S.
    Kim, B.
    Kim, H.
    Hong, D.
    Park, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy
    Duk Joo Lee
    Jeeyun Lee
    Ha Yeon Lee
    Taekyu Lim
    Su Jin Lee
    Seong Yoon Yi
    Se Hoon Park
    Joon Oh Park
    Ho Yeong Lim
    Won Ki Kang
    Young Suk Park
    Medical Oncology, 2011, 28 : 291 - 294
  • [27] Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy
    Lee, Duk Joo
    Lee, Jeeyun
    Lee, Ha Yeon
    Lim, Taekyu
    Lee, Su Jin
    Yi, Seong Yoon
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Young Suk
    MEDICAL ONCOLOGY, 2011, 28 : S291 - S294
  • [28] Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy
    Zhang, Yang
    Zhao, Liping
    Huang, Peiyu
    Wu, Jingxun
    Wang, Fenghua
    Huang, Yan
    Zhang, Li
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 611 - 615
  • [29] Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy
    Yang Zhang
    Liping Zhao
    Peiyu Huang
    Jingxun Wu
    Fenghua Wang
    Yan Huang
    Li Zhang
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 611 - 615
  • [30] A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer
    Kazuhisa Yamaguchi
    Hiroya Taniguchi
    Azusa Komori
    Yukiya Narita
    Sohei Nitta
    Motoo Nomura
    Shigenori Kadowaki
    Daisuke Takahari
    Takashi Ura
    Masashi Andoh
    Kei Muro
    Keita Mori
    Yoshinori Igarashi
    BMC Cancer, 15
12345